5-(Hydroxymethyl)cytidine

• UNSPSC Description:

  5-(Hydroxymethyl)cytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

• Target Antigen:

  Nucleoside Antimetabolite/Analog

• Type:

  Oligonucleotides

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Others; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/5-hydroxymethyl-cytidine.html

• Solubility:

  H2O : 20.83 mg/mL (ultrasonic)

• Smiles:

  NC(C(CO)=CN1[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)=NC1=O

• Molecular Weight:

  273.24

• References & Citations:

  [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

• Shipping Conditions:

  Blue Ice

• Clinical Information:

  No Development Reported

• CAS Number:

  19235-17-7